Medicare Enrolled

Dr. Laurence Holman, NURSE PRACTITIONER

Pain Medicine · Raleigh, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10880 DURANT RD STE 324, Raleigh, NC 27614
9197877246
In practice since 2010 (16 years)
NPI: 1972828457 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Holman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Holman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Holman

Dr. Laurence Holman is a pain medicine specialist in Raleigh, NC, with 16 years of NPI registration. Based on federal Medicare data, Dr. Holman performed 1,201 Medicare services across 482 unique beneficiaries.

Between the years covered by Open Payments, Dr. Holman received a total of $6,405 from 29 pharmaceutical and/or device companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Holman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 49% volume in NC $6,405 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,201
Medicare services
Top 49% in NC for pain medicine
482
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
560 $51 $133
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
312 $71 $200
Ketorolac injection, per 15 mg
An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg.
146 $0 $16
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
79 $61 $120
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
37 $8 $45
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
28 $112 $250
Definitive drug test using GC/MS or LC/MS
A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS.
24 $153 $300
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $107 $307
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,405
Total received (2018-2024)
Avg $915/year across 7 years
Top 20% in NC for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
222
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,405 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,407
2023
$2,389
2022
$1,382
2021
$723
2020
$138
2019
$199
2018
$167

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$496
Collegium Pharmaceutical, Inc.
$391
SI-BONE, INC.
$164
Abbott Laboratories
$84
Curonix LLC
$80
SPR Therapeutics, Inc
$77
Nalu Medical, Inc.
$62
VERTEX PHARMACEUTICALS INCORPORATED
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Top 3 companies account for 74.6% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$3,088
Collegium Pharmaceutical, Inc.
$1,045
BioDelivery Sciences International, Inc.
$291
Teva Pharmaceuticals USA, Inc.
$204
Scilex Pharmaceuticals Inc.
$200
Almatica Pharma LLC
$174
Abbott Laboratories
$171
SI-BONE, INC.
$164
SPR Therapeutics, Inc
$117
SCILEX PHARMACEUTICALS INC.
$109
GRT US Holding, Inc.
$99
Boston Scientific Corporation
$95
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$80
Curonix LLC
$80
Nalu Medical, Inc.
$78
Kowa Pharmaceuticals America, Inc.
$65
ARBOR PHARMACEUTICALS, INC.
$48
Biohaven Pharmaceuticals, Inc.
$42
Azurity Pharmaceuticals, Inc.
$39
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$39
VERTEX PHARMACEUTICALS INCORPORATED
$31
Averitas Pharma Inc.
$24
Electronic Waveform Lab, Inc.
$23
Biohaven Pharmaceutical Holding Company Ltd.
$20
NOVARTIS PHARMACEUTICALS CORPORATION
$18
Virtus Pharmaceuticals LLC
$18
Amneal Pharmaceuticals LLC
$17
PFIZER INC.
$15
Baudax Bio Inc.
$12
Top 3 companies account for 69.1% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANJESO · Accurian · BELBUCA · BUNAVAIL 2.1 mg 30-count box · Belbuca · ELYXYB - celecoxib · ETERNA · GRALISE · General - Pain Management · General - Therapies · Horizant · INCEPTIV · INTELLIS · INTELLIS ADAPTIVESTIM · LEVORPHANOL TARTRATE · LOREEV XR · LYVISPAH · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Nucynta · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · QUTENZA · Qutenza · RELISTOR · SPRINT PNS System · Seglentis · VANTA ADAPTIVESTIM · VECTRIS SURESCAN · XTAMPZA · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Raleigh?
Compare pain medicines in the Raleigh area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
4
Per 100K population
0.3
County median income
$101,763
Nearest hospital
TRIANGLE SPRINGS
8.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Holman is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 20% of NC peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Holman experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Holman performed 560 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Holman receive payments from pharmaceutical companies?
Yes. Dr. Holman received a total of $6,405 from 29 companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Holman's costs compare to other pain medicines in Raleigh?
Dr. Holman's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Holman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →